The stock of Gilead Sciences, Inc (NASDAQ:GILD) last traded at $91.86, down -0.57% from the previous session.
GILD stock price is now 2.29% away from the 50-day moving average and 20.06% away from the 200-day moving average. The market capitalization of the company currently stands at $113.83B.
On November 15, 2024, Wolfe Research recently initiated its ‘Outperform’ rating on the stock quoting a target price of $110, while ‘Citigroup’ rates the stock as ‘Buy’
In other news, Dickinson Andrew D, Chief Financial Officer sold 248,645 shares of the company’s stock on Nov 29 ’24. The stock was sold for $23,065,271 at an average price of $92.76. Upon completion of the transaction, the Chief Financial Officer now directly owns 138,919 shares in the company, valued at $12.76 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 27 ’24, Chief Medical Officer Parsey Merdad sold 164,211 shares of the business’s stock. A total of $15,094,013 was realized by selling the stock at an average price of $91.92. This leaves the insider owning 80,801 shares of the company worth $7.42 million. A total of 0.10% of the company’s stock is owned by insiders.
During the past 12 months, Gilead Sciences, Inc has had a low of $62.07 and a high of $98.90. As of last week, the company has a debt-to-equity ratio of 1.26, a current ratio of 1.26, and a quick ratio of 1.10. According to the stock market information, the enterprise value for the company is $130943754240, which is based on a 1035.57 price-to-earnings ratio, a 110.66 price-to-earnings-growth ratio, and a beta of 0.20. The fifty day moving average price for GILD is $89.8028 and a two-hundred day moving average price translates $76.50785 for the stock.
The latest earnings results from Gilead Sciences, Inc (NASDAQ: GILD) was released for 2024-09-30. The net profit margin was 0.45% and return on equity was 0.62% for GILD. The company reported revenue of $7.54 billion for the quarter, compared to $7.05 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.01 percent.
